Accelerate Diagnostics, Inc.
AXDX
$0.65
-$0.045-6.48%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -6.97% | -9.82% | 2.23% | 3.88% | 1.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.97% | -9.82% | 2.23% | 3.88% | 1.85% |
| Cost of Revenue | -1.13% | -33.62% | 8.86% | 22.04% | 12.34% |
| Gross Profit | -29.07% | 700.00% | -15.39% | -28.49% | -24.73% |
| SG&A Expenses | -20.47% | -27.38% | -28.89% | -43.53% | -33.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -21.87% | -35.41% | -25.24% | -30.71% | -18.75% |
| Operating Income | 26.08% | 41.17% | 31.62% | 36.77% | 23.14% |
| Income Before Tax | 22.35% | -1,506.24% | 64.43% | 15.27% | 15.33% |
| Income Tax Expenses | -111.70% | -- | -- | -- | 832.47% |
| Earnings from Continuing Operations | 26.23% | -1,708.68% | 64.60% | 15.27% | 11.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 26.23% | -1,708.68% | 64.60% | 15.27% | 11.03% |
| EBIT | 26.08% | 41.17% | 31.62% | 36.77% | 23.14% |
| EBITDA | 28.11% | 44.05% | 34.33% | 39.07% | 24.74% |
| EPS Basic | 57.34% | -1,032.70% | 83.10% | 56.66% | 40.49% |
| Normalized Basic EPS | -1,710.39% | 61.05% | 69.48% | 56.62% | 102.42% |
| EPS Diluted | 57.34% | -1,032.70% | 83.10% | 56.70% | 40.64% |
| Normalized Diluted EPS | -1,710.39% | 61.05% | 69.48% | 56.62% | 102.42% |
| Average Basic Shares Outstanding | 72.92% | 72.63% | 109.45% | 95.48% | 49.52% |
| Average Diluted Shares Outstanding | 72.92% | 72.63% | 109.45% | 95.48% | 49.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
